MCAM and nasopharyngeal carcinoma: HuMETCAM/MUC18 appeared to play a tumor suppressor role in the development of this type of NPC by mediating elevated apoptosis and decreased anti-apoptosis, angiogenesis, proliferation, and the metabolic switch to aerobic glycolysis.